Comment on Investment Tide of Proton and Heavy Ion Irradiation
-
-
-
[1] Suit HD, Chu W. History of charged particle radiotherapy[M]// DeLaney TF, Kooy HM. Proton and Charged Particle Radiotherapy. Wolter Kluwe: Lippincoot Williams and Wilkins, 2008: 1-7.
[2] Bush DA, Cheek G, Zaheer S, et al. High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center[J]. Int J Radiat Oncol Biol Phys, 2013, 86(5): 964-8. doi: 10.1016/j.ijrobp.2013.05.002
[3] Ling TC, Kang JI, Bush DA, et al. Proton therapy for hepatocellular carcinoma[J]. Chin J Cancer Res, 2012, 24(4): 361-7. doi: 10.1007/s11670-012-0276-7
[4] Matsunobu A, Imai R, Kamada T, et al. Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk. Working Group for Bone and Soft Tissue Sarcomas[J]. Cancer, 2012, 118(18): 4555-63. doi: 10.1002/cncr.27451
[5] Imai R, Kamada T, Araki N, et al. Carbon ion radiation therapy for unresectable sacral chordoma: An Analysis of 188 Cases[J]. Int J Radiat Oncol Biol Phys, 2016, 95(1): 322-7. doi: 10.1016/j.ijrobp.2016.02.012
[6] Ishikawa H, Tsuji H, Kamada T, et al. Carbon-ion radiation therapy for prostate cancer[J]. Int J Urol, 2012, 19(4): 296-305. doi: 10.1111/iju.2012.19.issue-4
[7] Kamada T, Tsujii H, Blakely EA, et al. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience[J]. Lancet Oncol, 2015, 16(2): e93-e100. doi: 10.1016/S1470-2045(14)70412-7
[8] Rosenblatt E, Meghzifene A, Belyakov O, et al. Relevance of Particle Therapy to Developing Countries[J]. Int J Radiat Oncol Biol Phys, 2016, 95(1): 25-9. doi: 10.1016/j.ijrobp.2015.12.370
计量
- 文章访问数: 1943
- HTML全文浏览量: 594
- PDF下载量: 1865
下载:
